There's still value in biotech stocks: Citi pro
April 07, 2014 at 18:23 PM EDT
Despite the recent meltdown in biotechnology stocks, there are still areas of opportunity within the sector, Citi's Yaron Werber says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.